Skip to main content
Clinical Trials/CTRI/2022/04/041659
CTRI/2022/04/041659
Completed
Phase 2

Repertorial approach of treating menstrual irregularities withindividualized homoeopathic medicines in early reproductive age group: A Double-blind, randomized, placebo-controlled efficacy trial

D N De Homoeopathic Medical College and Hospital0 sites92 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N926- Irregular menstruation, unspecified
Sponsor
D N De Homoeopathic Medical College and Hospital
Enrollment
92
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 13, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
D N De Homoeopathic Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients suffering from menstrual irregularities (ICD 10: N92\.6\)
  • 2\. Differential diagnosis established by USG and other laboratory investigations as appropriate.
  • 3\. Age: 11\-25 years.
  • 4\. Patients taking oral contraceptive pills will be considered for the study after giving a wash\-out period of 1 month.
  • 5\. Literate patients, who can read and write in Bengali, and/or English.
  • 6\. Patients giving written informed consent to participate in the study

Exclusion Criteria

  • 1\. Patients suffering from carcinoma of cervix, chronic tubo\-ovarian mass, endometrial carcinoma, genital tuberculosis.
  • 2\. Vulnerable population â?? unconscious, ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people.
  • 3\. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled
  • or life\- threatening illness affecting quality of life or any organ failure.
  • 4\. Blood haemoglobin level less than 7g/dl.
  • 5\. Participants with habits of tobacco chewing and/or smoking, alcoholism and/or any other
  • form(s) of substance abuse and/or dependence.
  • 6\. Self\-reported immune\-compromised state.
  • 7\. Undergoing homeopathic treatment for any chronic disease within last 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials